Tacrolimus Treatment for Refractory Autoimmune Cytopenia

Clinical trial NCT03918265 · UNKNOWN

Trial details

NCT number: NCT03918265
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Autoimmune Hemolytic Anemia Pure Red Cell Aplasia Evans Syndrome

Start date: 2019-05-04
Primary completion: 2020-08-10
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.